SNY/N Stock Price and Chart — BIVA:SNY/N — TradingView

Overview

Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

SNY/N chart

Key facts today

Sanofi reported positive trial results for its inflammatory bowel disease (IBD) treatment, demonstrating a higher endoscopic response in patients with Crohn's disease when compared to a placebo group.

Sanofi has projected a currency impact on its Q4 2024 sales, estimating a decrease of between -1% and -2%, while the anticipated impact on Q4 business EPS is estimated to be between -4% and -5%.

Analyze the impact Analyze the impact

Key stats

Employees

About SANOFI

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

Financials

Performance

Revenue to profit conversion

Debt level and coverage

Earnings

Next:—

Ideas

See all ideas

Technicals

Summarizing what the indicators are suggesting.

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

An aggregate view of professional's ratings.

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Seasonals

Displays a symbol's price movements over previous years to identify recurring trends.

SNY/N highest yielding bonds

4.58%

Jun 19, 2028

3.21%

Mar 21, 2038

3.02%

Apr 1, 2025

2.92%

Mar 21, 2034

2.75%

Mar 21, 2030

2.70%

Mar 21, 2029

2.67%

Apr 1, 2030

2.66%

Apr 6, 2029

2.64%

Sep 10, 2026

2.62%

Mar 21, 2026

2.57%

Jan 13, 2027

Explore more bonds

Curated watchlists where SNY/N is featured.

Big pharma stocks: Top pharmaceutical firms

See all sparks

The current price of SNY/N is 1,002.34 MXN — it has decreased by −9.75% in the past 24 hours. Watch SANOFI stock price performance more closely on the chart.

Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange SANOFI stocks are traded under the ticker SNY/N.

SNY/N stock has fallen by −3.95% compared to the previous week, the month change is a −7.71% fall, over the last year SANOFI has showed a 24.51% increase.

We've gathered analysts' opinions on SANOFI future price: according to them, SNY/N price has a max estimate of 1,331.74 MXN and a min estimate of 899.93 MXN. Watch SNY/N chart and read a more detailed SANOFI stock forecast: see what analysts think of SANOFI and suggest that you do with its stocks.

SNY/N stock is 8.43% volatile and has beta coefficient of 0.10. Track SANOFI stock price on the chart and check out the list of the most volatile stocks — is SANOFI there?

Today SANOFI has the market capitalization of ‪2.32 T‬, it has decreased by −3.88% over the last week.

Yes, you can track SANOFI financials in yearly and quarterly reports right on TradingView.

SNY/N net income for the last half-year is ‪44.53 B‬ MXN, while the previous report showed ‪36.19 B‬ MXN of net income which accounts for 23.03% change. Track more SANOFI financial stats to get the full picture.

Yes, SNY/N dividends are paid annually. The last dividend per share was 24.83 MXN. As of today, Dividend Yield (TTM)% is 3.22%. Tracking SANOFI dividends might help you take more informed decisions.

SANOFI dividend yield was 2.97% in 2023, and payout ratio reached 63.38%. The year before the numbers were 2.84% and 39.20% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.

As of Dec 18, 2024, the company has ‪87.99 K‬ employees. See our rating of the largest employees — is SANOFI on this list?

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SANOFI EBITDA is ‪274.23 B‬ MXN, and current EBITDA margin is 30.09%. See more stats in SANOFI financial statements.

Like other stocks, SNY/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SANOFI stock right from TradingView charts — choose your broker and connect to your account.

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SANOFI technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SANOFI stock shows the buy signal. See more of SANOFI technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.